An infectious disease expert from the University of Birmingham is playing a significant part in the fight against COVID-19 as one of the leads at the Government's first flagship COVID-19 testing facility.
An innovative treatment for patients with Clostridium difficile infection, which uses transplanted gut bacteria to treat the infection, is a more effective and more cost-efficient treatment than using antibiotics.
NitroPep, developed by researchers at the University of Birmingham and led by Dr Felicity de Cogan, has won the Health and Wellbeing category in the 2020 Katerva Awards.
University of Birmingham microbiology expert Professor Robin May has been appointed Chief Scientific Adviser to the Food Standards Agency.
A new study from the University of Birmingham has shown that Faecal Microbiota Transplants (FMT) are highly successful in treating patients with Clostridioides difficile (C.diff) infection.
The Birmingham Health Partners ecosystem has been awarded Life Sciences Opportunity Zone status by the Department for Business, Energy and Industrial Strategy.
Probiotic drink could offer new way to combat antibiotic resistance
Dr Naa Dei Nikoi has won a prestigious Royal Academy of Engineering Enterprise Fellowship to advance work on a novel method of drug delivery for diseases that can cause loss of vision.
Rapid test for gonorrhoea and chlamydia to be developed by University of Birmingham spinout
The face of the University of Birmingham's 'Old Joe' Clock tower will be lit blue to shine a light on the work scientists are doing to discover new ways to prevent and treat drug-resistant bacterial infections.
UK and China scientists developing new drugs to fight tuberculosis
Dr Enea Sancho-Vaello has been appointed as a Marie Sklodowska Curie Postdoctoral Fellow in the laboratory of Dr Jessica Blair, Institute of Microbiology and Infection.